Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Conducting Photostability Testing for Gels – V 2.0

Posted on By

Gel Manufacturing: SOP for Conducting Photostability Testing for Gels – V 2.0

Standard Operating Procedure for Conducting Photostability Testing on Gel Formulations


Department Gel Manufacturing
SOP No. SOP/GM/109/2025
Supersedes SOP/GM/109/2022
Page No. Page 1 of 12
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2027

1. Purpose

To describe the procedure for performing photostability testing on gel formulations in accordance with ICH Q1B guidelines to determine the light sensitivity and stability profile of the product.

2. Scope

This procedure applies to all new and existing pharmaceutical gel products manufactured in the facility that require photostability testing for regulatory submission

or product development purposes.

3. Responsibilities

  • Stability Analyst: Prepares and exposes samples under defined conditions.
  • Quality Control (QC): Performs analysis of photostressed samples.
  • Quality Assurance (QA): Reviews and approves the test plan and outcome.
  • R&D/Formulation Development: Evaluates the formulation impact in case of degradation.
See also  Gel Manufacturing: SOP for Cleaning Logs Documentation for Mixing Vessels - V 2.0

4. Accountability

Head – Quality Assurance is accountable for ensuring compliance with regulatory guidelines and proper execution of photostability testing procedures.

5. Procedure

5.1 Preparation

  1. Obtain representative samples of the gel product in its market pack and container-closure system.
  2. Label each sample clearly with batch number, exposure date, and time.
  3. Place the control (dark) sample and exposed sample in different containers for comparison.

5.2 Exposure Conditions

  1. Use a validated photostability chamber that complies with ICH Q1B Option 2 (fluorescent and near UV lamps).
  2. Ensure exposure to a minimum of 1.2 million lux hours and 200 watt-hours/m² of near UV energy.
  3. Maintain chamber temperature between 25°C to 30°C.

5.3 Sample Placement

  1. Place exposed samples evenly on a rotating platform within the chamber to ensure uniform exposure.
  2. Wrap the control samples in aluminum foil or place in a light-opaque container.
See also  Gel Manufacturing: SOP for Cleaning Validation of Gel Manufacturing Equipment - V 2.0

5.4 Duration and Monitoring

  1. Expose samples for a period sufficient to reach the specified lux and UV exposure levels.
  2. Monitor and document lux and UV levels using calibrated sensors at set intervals.

5.5 Evaluation of Samples

  1. After exposure, retrieve the samples and store at ambient conditions until analysis.
  2. Perform visual inspection for discoloration, phase separation, and turbidity.
  3. Conduct chemical tests for assay, degradation products, pH, and viscosity using validated methods.

5.6 Documentation and Reporting

  1. Document all test data in the Photostability Testing Log (Annexure-1).
  2. Prepare the Photostability Test Summary Report (Annexure-2).
  3. Submit findings to QA for review and sign-off.

6. Abbreviations

  • QA: Quality Assurance
  • QC: Quality Control
  • ICH: International Council for Harmonisation
  • UV: Ultraviolet
  • Lux: Unit of illumination

7. Documents

  1. Photostability Protocol – Annexure-1
  2. Photostability Summary Report – Annexure-2
  3. Chamber Qualification Record
See also  Gel Manufacturing: SOP for Adding Preservatives to Gel Formulations - V 2.0

8. References

  • ICH Q1B: Photostability Testing of New Drug Substances and Products
  • WHO Technical Report Series No. 1010
  • PharmaSOP – Stability Testing SOP

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Photostability Testing Log

Batch No.
Exposure Start Date
Exposure End Date
Exposure Conditions Lux: __________ | UV: __________
Temperature (°C)
Visual Appearance
Remarks

Annexure-2: Photostability Test Summary Report

Test Parameter Initial Result Post-Exposure Result Limit Conclusion
Assay (%)
Degradation Products (%)
pH
Viscosity (cP)

Revision History

Revision Date Revision No. Change Description Reason Approved By
16/05/2022 1.0 Initial Issue New SOP QA Head
02/06/2025 2.0 Aligned with ICH Q1B Option 2 and added annexures Regulatory Compliance QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Investigations of Complaints Related to Injectable Products – V 2.0
Next Post: Biosimilars: SOP for Shift Handover Procedures – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version